November 16, 2026
Business

EQT Life Sciences-Backed AgomAb Falls After $200 Million IPO(Soban News)

AgomAb Therapeutics NV, a clinical-stage biopharmaceutical company backed by EQT Life Sciences, closed 8.4% below its IPO price in its trading debut Friday after the firm raised $200 million in a listing.

​AgomAb Therapeutics NV, a clinical-stage biopharmaceutical company backed by EQT Life Sciences, closed 8.4% below its IPO price in its trading debut Friday after the firm raised $200 million in a listing. by Soban News (international And National News)

Related posts

JPMorgan downgrades India to ‘neutral’ on valuations, earnings risks(Soban News)

News-Soban-Admin

‘Only one or two stitches’: Iran says Mojtaba Khamenei sustained ‘superficial’ injuries during… – Moneycontrol.com(Soban News)

News-Soban-Admin

‘Asim Munir Is Running Pakistan’: Ex-Pak Minister Says Trump Ignores Shehbaz Sharif Altogether – News18(Soban News)

News-Soban-Admin

Leave a Comment